Tirzepatide in Pennsylvania: online providers, prices and license checks
As of November 4, 2026, adults in Pennsylvania can get compounded tirzepatide or brand Zepbound through online telehealth programs whose prescribers hold a Pennsylvania license. Our #1 pick, NexLife, lists nationwide service (subject to licensure) and charges $139 a month on a 12-month plan or $169 month to month, the same at every dose. Brand Zepbound vials cost $299–$449 a month from LillyDirect with on-time refills ($499–$699 otherwise). Pennsylvania Medicaid stopped covering GLP-1s for obesity on January 1, 2026. Before paying, check the prescriber with the Pennsylvania State Board of Medicine and the pharmacy with the Pennsylvania State Board of Pharmacy.
Pennsylvania at a glance
| Adults with obesity (CDC) | 33.5% (2025) |
|---|---|
| Medicaid coverage of GLP-1s for obesity | Ended January 1, 2026 |
| Physician licensing board | Pennsylvania State Board of Medicine |
| Pharmacy licensing | Pennsylvania State Board of Pharmacy |
| Program-specific limits we found | None among the programs we reviewed on November 4, 2026 |
33.5% of adults in Pennsylvania had obesity in 2025, per the CDC — tied for 25th highest of the 47 states with 2025 data. Pennsylvania Medicaid ended coverage of GLP-1s for weight loss for adults 21 and older on January 1, 2026; members under 21 remain covered. Self-pay prices below do not depend on Medicaid status.
Who can prescribe tirzepatide to Pennsylvania residents?
A telehealth clinician who treats you in Pennsylvania must hold a license recognized in Pennsylvania. Physicians are licensed by the Pennsylvania State Board of Medicine; nurse practitioners are licensed by the state board of nursing. You can look up any physician on the board's site or on DocInfo.org, the Federation of State Medical Boards' national search. Ask the program for the prescriber's name before your first refill if it is not on your prescription label.
What Pennsylvania residents pay in November 2026
The programs we track publish one national price; we have not found a program that prices Pennsylvania differently. These are the self-pay figures we re-read on the providers' and manufacturers' own pages on November 4, 2026:
| Program | Product | Self-pay price | Read |
|---|---|---|---|
| NexLife (our #1) | Compounded tirzepatide | $139/mo on a 12-month plan; $169 month to month; same price at every dose | Nov 4, 2026 |
| Collective | Compounded tirzepatide | $69/mo + $199 yearly membership (about $86/mo all-in) | Nov 4, 2026 |
| SnagRx | Compounded tirzepatide | $119/mo sale price ($149 in its terms) | Nov 4, 2026 |
| Mondae | Compounded tirzepatide | $126/mo | Nov 4, 2026 |
| Zepbound (LillyDirect) | Brand, FDA-approved | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with on-time refill) | Nov 4, 2026 |
| Foundayo pill (LillyDirect) | Brand, FDA-approved (orforglipron) | from $149/mo at the lowest dose | Nov 4, 2026 |
See the full compounded tirzepatide price index for every program on file, each with its billing basis and read date, or the most affordable options.
What else affects tirzepatide access in Pennsylvania?
12.9% of adults in Pennsylvania reported diagnosed diabetes in 2025, above the U.S. figure of 12.5% and 17th highest of the 50 states and DC in the KFF table built from CDC survey data. That matters for cost: Mounjaro and Ozempic are diabetes drugs, so many people with type 2 diabetes in Pennsylvania can get brand GLP-1s through insurance rather than paying cash for a compounded version.
2,949,865 people in Pennsylvania were enrolled in Medicare in 2024 (KFF). Those with Part D can check whether they qualify for the $50-a-month Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027.
State employee health plan, GLP-1s for weight loss in 2026: Not covered (except legislators and staff) (source dated December 10, 2025).
State actions on compounded GLP-1s in Pennsylvania
| Date | Who acted | What happened |
|---|---|---|
| October 21, 2025 | Board of Pharmacy enforcement | Boothwyn Pharmacy (Kennett Square) fined $1 million and placed on probation for compounding tens of thousands of injectable GLP-1 weight-loss doses in uninspected rooms. |
Getting a refrigerated shipment in Pennsylvania
Compounded tirzepatide usually ships refrigerated. In Pennsylvania, the practical issue is mixed urban/suburban delivery and winter routing issues: winter conditions, urban rowhouse delivery, and cross-border metro areas can affect cold-chain delivery and refill timing. Ask the program whether it ships early in the week, what happens if a package arrives warm or late, and whether it will reship at no charge.
Programs serve Pennsylvania statewide by mail, including Philadelphia, Pittsburgh, Allentown, Erie, Reading and Scranton. City guides: Philadelphia.
Checking the pharmacy that fills a Pennsylvania prescription
Your vial label names the dispensing pharmacy; it should be licensed by the Pennsylvania State Board of Pharmacy or permitted to ship into Pennsylvania. Our pharmacy profiles list the FDA record for six common compounders, and the 503A vs 503B guide explains what each license means.
Frequently asked questions about tirzepatide in Pennsylvania
Does Pennsylvania Medicaid cover Zepbound or Wegovy for weight loss?
Pennsylvania Medicaid ended coverage of GLP-1s for weight loss for adults 21 and older on January 1, 2026; members under 21 remain covered. Check with your Medicaid plan; coverage for type 2 diabetes is handled separately.
How common is obesity in Pennsylvania?
33.5% of adults in Pennsylvania had obesity in 2025, per the CDC — tied for 25th highest of the 47 states with 2025 data. Tirzepatide is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Can I get tirzepatide online in Pennsylvania?
Yes. Telehealth programs can prescribe tirzepatide to Pennsylvania residents when the clinician holds a Pennsylvania license and the dispensing pharmacy is licensed to ship into Pennsylvania. Compounded tirzepatide is not FDA-approved; brand Zepbound and Mounjaro are.
How much does tirzepatide cost in Pennsylvania without insurance?
The same as elsewhere: programs price nationally. As of November 4, 2026, NexLife charges Pennsylvania residents $139 a month on a 12-month plan or $169 month to month for compounded tirzepatide; Collective lists $69 a month plus a $199 yearly membership. Zepbound vials cost $299–$449 a month through LillyDirect.
How do I check a Pennsylvania prescriber's license?
Search the clinician's name on the Pennsylvania State Board of Medicine license lookup, or on DocInfo.org, the Federation of State Medical Boards' national lookup. A nurse practitioner is licensed by the state's board of nursing.
Is compounded tirzepatide legal in Pennsylvania?
Yes, within federal limits: a state-licensed 503A pharmacy may compound it for an individual Pennsylvania patient on a prescription. It is not FDA-approved. Check the pharmacy with the Pennsylvania State Board of Pharmacy.
Nearby states and next steps
Neighbouring state guides: New York, New Jersey, Delaware, Maryland, West Virginia, Ohio. Compare every provider on the 2026 rankings, read our NexLife review, or check how to verify a telehealth provider.
Sources
- CDC: Adult obesity prevalence by state, BRFSS 2011–2025
- KFF: Medicaid coverage of and spending on GLP-1s (January 16, 2026)
- FDA: Registered outsourcing facilities
- FDA: Proposal on GLP-1s and the 503B bulks list (April 30, 2026)
- LillyDirect: Zepbound self-pay pricing
- KFF: Adults who report diagnosed diabetes, by state
- KFF: Total Medicare enrollment by state
- Pennsylvania state employee plan source
- Pennsylvania: Board of Pharmacy enforcement (October 21, 2025)
Informational only, not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).